S’ heels of senescent cells, Y. Zhu et al.(A) (B)(C)(D)(E)(F)(G)(H)(I)Fig. 3 Dasatinib and quercetin reduce senescent cell abundance in mice. (A) Effect of D (250 nM), Q (50 lM), or D+Q on levels of senescent Ercc1-deficient murine embryonic fibroblasts (MEFs). Cells were exposed to drugs for 48 h prior to analysis of SA-bGal+ cells using C12FDG. The data shown are means ?SEM of three replicates, ***P < 0.005; t-test. (B) Effect of D (500 nM), Q (100 lM), and D+Q on senescent bone marrow-derived mesenchymal stem cells (BM-MSCs) from progeroid Ercc1?D mice. The senescent MSCs were exposed to the drugs for 48 SART.S23503 h prior to analysis of SA-bGal activity. The data shown are means ?SEM of three replicates. **P < 0.001; ANOVA. (C ) The senescence markers, SA-bGal and p16, are reduced in inguinal fat of 24-month-old mice treated with a single dose of senolytics (D+Q) compared to vehicle only (V). Cellular SA-bGal activity assays and p16 expression by RT CR were carried out 5 days after treatment. N = 14; means ?SEM. **P < 0.002 for SA-bGal, *P < 0.01 for p16 (t-tests). (E ) D+Q-treated mice have fewer liver p16+ cells than vehicle-treated mice. (E) Representative images of p16 mRNA FISH. Cholangiocytes are located between the white dotted lines that indicate the luminal and outer borders of bile canaliculi. (F) Semiquantitative analysis of fluorescence intensity demonstrates decreased cholangiocyte p16 in drug-treated animals compared to vehicle. N = 8 animals per group. *P < 0.05; Mann hitney U-test. (G ) Senolytic agents decrease p16 expression in quadricep muscles (G) and cellular SA-bGal in inguinal fat (H ) of radiation-exposed mice. Mice with one leg exposed to 10 Gy radiation 3 months previously developed gray hair (Fig. 5A) and senescent cell accumulation in the radiated leg. Mice were treated once with D+Q (solid bars) or vehicle (open bars). After 5 days, cellular SA-bGal activity and p16 mRNA were assayed in the radiated leg. N = 8; means ?SEM, p16: **P < 0.005; SA b-Gal: *P < 0.02; t-tests.p21 and PAI-1, both regulated by p53, dar.12324 are implicated in protection of cancer and other cell types from apoptosis (Gartel Radhakrishnan, 2005; Kortlever et al., 2006; Schneider et al., 2008; Vousden Prives,2009). We found that p21 siRNA is senolytic (Fig. 1D+F), and PAI-1 siRNA and the PAI-1 inhibitor, tiplaxtinin, also may have some senolytic activity (Fig. S3). We found that siRNA against another serine protease?2015 The Authors. Aging Cell published by the Anatomical Society and John Wiley Sons Ltd.Senolytics: Achilles’ heels of senescent cells, Y. Zhu et al.(A)(B)(C)(D)(E)(F)Fig. 4 Effects of senolytic agents on cardiac (A ) and vasomotor (D ) function. D+Q significantly improved left ventricular ejection fraction of 24-month-old mice (A). Improved systolic function did not occur due to increases in cardiac preload (B), but was instead a result of a reduction in end-systolic dimensions (C; Table 
S3). D+Q resulted in modest improvement in endothelium-dependent relaxation elicited by acetylcholine (D), but profoundly improved vascular smooth muscle cell relaxation in response to nitroprusside (E). Contractile responses to U46619 (F) were not significantly altered by D+Q. In Sitravatinib web panels D , relaxation is expressed as the percentage of the preconstricted baseline value. Thus, for panels D , lower values indicate improved vasomotor function. N = 8 male mice per group. *P < 0.05; A : t-tests; D : ANOVA.inhibitor (serpine), PAI-2, is senolytic (Fig. 1D+.
